Table 2 |
||||||||||
|
Distribution of ER- samples among clusters, prognostic groups and intrinsic subtypes |
||||||||||
|
Cluster |
n |
Outcome |
LI |
ER- |
||||||
|
Good |
Poor |
High |
Low |
Luminal B |
Luminal A |
Normal |
Basal |
HER2 |
||
|
|
||||||||||
|
CC+/IR+ |
39 |
25 |
14 |
7 |
2 |
0 |
0 |
0 |
38 |
1 |
|
CC+ |
37 |
18 |
17 |
3 |
5 |
0 |
0 |
1 |
33 |
3 |
|
ECM+ |
45 |
26 |
18 |
1 |
14 |
0 |
9 |
9 |
22 |
5 |
|
SR+ |
36 |
16 |
20 |
2 |
4 |
1 |
1 |
0 |
2 |
32 |
|
IR+ |
29 |
23 |
6 |
6 |
6 |
0 |
4 |
2 |
9 |
14 |
|
|
||||||||||
|
For the five clusters of Figure 2a, we give the number of samples per cluster (n) and their distributions over good/poor outcome, high/low lymphocytic infiltration (LI) score, and intrinsic subtypes as determined by the single sample predictor (SSP) classifier. Clusters were labeled by the main Gene Ontology of genes over-expressed in the group: CC+ (cell cycle), CC+/IR+ (cell cycle and immune response), ECM+ (extracellular matrix), SR+ (steroid hormone response), and IR+ (immune response). ER, estrogen receptor. |
||||||||||
|
Teschendorff et al. Genome Biology 2007 8:R157 doi:10.1186/gb-2007-8-8-r157 |
||||||||||